Sign in
Taking people in South KoreaNo phase

Tests brain stimulation to help swallowing after stroke

Tests brain stimulation against fake stimulation in adults with stroke-related swallowing trouble.

Key facts

Who runs it
NEUROPHET
Where
Bucheon-si, South KoreaSee the site
Trial code
Registry title
Clinical Trial on the Safety and Efficacy of Optimized Transcranial Direct Current Stimulation for the Swallowing Function in Patients With Post-Stroke Dysphagia
Status
Recruiting
People taking part
30 people, planned
Started
22 Apr 2024
Planned end
30 Jun 2026
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Optimized transcranial Direct Current Stimulation
  • Sham transcranial Direct Current Stimulation
Record updated
9 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who had a first stroke and now have swallowing problems. It tests brain stimulation against a sham (fake) stimulation.

Age
Older than 19 years
Sex
Men and women
Disease stage
First-time stroke confirmed by brain imaging, 3 weeks or more after the stroke (subacute or chronic phase), with swallowing problems (dysphagia) confirmed by a swallowing X-ray test (VFSS).
Earlier treatment
Cannot have used a similar stimulation device in the last year or taken part in related trials.

Main reasons for not taking part

  • Repeated stroke, brain or spinal cord injury, or brain disease such as Parkinson's disease
  • Confusion, delirium or thinking problems that prevent following the trial
  • Pacemaker, cochlear implant, metal at the electrode area or a scalp problem
  • Epilepsy not under control within the last 6 months
  • Pregnant, breastfeeding or planning pregnancy during the trial

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • men and women >19 years old
  • patients with stroke confirmed by neuroimaging
  • first-time stroke patients
  • patients in subacute or chronic phases of stroke with 3 weeks or more after onset
  • stroke patients with confirmed dysphagia through Videofluoroscopic Swallowing Study (VFSS)

Who cannot take part

  • patients with previous experience within the last year using a stimulation device similar to the one use in this clinical trial or who have participated in related clinical trials
  • patients with severe neurologic disorder with concomitant major psychiatric disorder such as major depressive disorder and dementia
  • patients who are taken contraindicated medications or require medication changes during the trial period that could influence cognitive/motor function changes via brain activation changes
  • patients with recurrent stoke, traumatic brain injury, spine cord injury, and degenerative brain disease, such as Parkinson's disease, etc
  • patients with evidence of delirium, confusion, or other impairment of consciousness
  • patients with uncontrolled medical disease or surgical conditions
  • patients ineligible for Transcranial direct current stimulation (due to scalp condition, metallic material at the electrode attachment area, presence of a pacemaker or cochlear implant)
  • patients with history of uncontrolled epilepsy within 6 months
  • patients with deteriorated cognitive function unable to perform the clinical trial as instructed
  • patients with medical contraindications for neuroimaging test, such as MRI
  • patients who are pregnant, breastfeeding, or planning pregnancy during the trial period
  • patients considered medically ineligible for participation in the present trial beyond the criteria listened above

Where in South Korea

  • The Catholic University of Korea, Bucheon St. Mary's HospitalBucheon-si, South KoreaContact: TaeYeong KimTaking people

About the trial

What the trial wants to find out

The goal of this clinical trial is to evaluate whether the application of optimized transcranial direct current stimulation is more effective compared to sham stimulation for temporary improvement of swallowing function in patients with post-stroke dysphagia.

The 2 groups in the trial

  • Optimized transcranial Direct Current StimulationTreatment being tested

    Patients receive optimized stimulation obtained from an individualized T1 MRI-based simulation of transcranial direct current stimulation for 30 minutes, once a day for 4 weeks, for a total of 20 sessions.

  • Sham transcranial Direct Current StimulationSham treatment, for comparison

    Patients receive sham stimulation for 30 minutes, once a day for 4 weeks, for a total of 20 sessions.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multi-center, Randomized, Double-blind, Pilot Study to Evaluate the Safety and Efficacy of Optimized Transcranial Direct Current Stimulation for the Transitory Improvement of Swallowing Function in Patients With Post-stroke Dysphagia
Plain-language title
Tests brain stimulation to help swallowing after strokeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
9 April 2026